Loading...
Indivior PLC
INDV.L•LSE
HealthcareDrug Manufacturers - Specialty & Generic
£1015.00
£26.50(2.68%)
Indivior PLC (INDV.L) Financial Performance & Statements
Review Indivior PLC’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
8.69%
↑ 8.69%
Operating Income Growth
900.00%
↑ 900.00%
Net Income Growth
0.00%
Operating Cash Flow Growth
111.43%
↑ 111.43%
Operating Margin
2.90%
↑ 2.90%
Gross Margin
80.44%
↑ 80.44%
Net Profit Margin
0.26%
↑ 0.26%
ROE
-1.30%
↓ 1.30%
ROIC
9.19%
↑ 9.19%
Indivior PLC (INDV.L) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Indivior PLC stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $299.00M | $307.00M | $299.61M | $282.74M |
| Cost of Revenue | $23.00M | $69.00M | $116.24M | $52.76M |
| Gross Profit | $276.00M | $238.00M | $183.37M | $229.97M |
| Gross Profit Ratio | $0.92 | $0.78 | $0.61 | $0.81 |
| R&D Expenses | $31.00M | $22.63M | $27.05M | $27.88M |
| SG&A Expenses | -$47.00M | $208.00M | $121.25M | $135.39M |
| Operating Expenses | $180.00M | $234.00M | $148.30M | $163.27M |
| Total Costs & Expenses | $203.00M | $303.00M | $264.54M | $216.03M |
| Interest Income | $6.00M | $5.00M | $6.00M | $6.00M |
| Interest Expense | $13.00M | $10.00M | $9.00M | $8.00M |
| Depreciation & Amortization | $5.00M | -$10.00M | $25.05M | $8.96M |
| EBITDA | $106.00M | $9.00M | -$101.21M | $80.64M |
| EBITDA Ratio | $0.35 | $0.03 | -$0.34 | $0.29 |
| Operating Income | $96.00M | $4.00M | $35.07M | $66.70M |
| Operating Income Ratio | $0.32 | $0.01 | $0.12 | $0.24 |
| Other Income/Expenses (Net) | -$8.00M | -$5.00M | -$3.00M | -$2.00M |
| Income Before Tax | $88.00M | -$1.00M | -$135.27M | $62.72M |
| Income Before Tax Ratio | $0.29 | -$0.003 | -$0.45 | $0.22 |
| Income Tax Expense | $28.00M | -$5.00M | -$28.06M | $15.93M |
| Net Income | $59.00M | $4.00M | -$107.22M | $47.00M |
| Net Income Ratio | $0.20 | $0.01 | -$0.36 | $0.17 |
| EPS | $0.45 | $0.03 | -$0.80 | $0.34 |
| Diluted EPS | $0.44 | $0.03 | -$0.80 | $0.34 |
| Weighted Avg Shares Outstanding | $132.00M | $132.10M | $134.85M | $135.74M |
| Weighted Avg Shares Outstanding (Diluted) | $133.00M | $133.55M | $134.85M | $138.71M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan